Surgery Partners (NASDAQ:SGRY) Price Target Lowered to $29.00 at UBS Group

Surgery Partners (NASDAQ:SGRY) had its target price cut by UBS Group from $34.00 to $29.00 in a research note published on Thursday,Benzinga reports. They currently have a buy rating on the stock.

SGRY has been the subject of several other research reports. Royal Bank Of Canada dropped their price target on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday. Weiss Ratings restated a “sell (d-)” rating on shares of Surgery Partners in a research note on Wednesday, October 8th. Benchmark reduced their price target on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating on the stock in a research report on Tuesday. Bank of America initiated coverage on Surgery Partners in a research note on Monday, July 28th. They set a “buy” rating and a $28.00 price objective on the stock. Finally, JPMorgan Chase & Co. initiated coverage on shares of Surgery Partners in a research note on Thursday, September 18th. They set a “neutral” rating and a $27.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $29.75.

Surgery Partners Price Performance

SGRY traded down $0.03 during trading on Thursday, reaching $15.28. 3,050,845 shares of the stock were exchanged, compared to its average volume of 1,468,750. Surgery Partners has a 1 year low of $15.12 and a 1 year high of $26.16. The company has a market capitalization of $1.96 billion, a price-to-earnings ratio of -10.69 and a beta of 1.85. The business’s 50 day moving average price is $20.93 and its two-hundred day moving average price is $21.96. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, November 10th. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The firm had revenue of $821.50 million during the quarter, compared to analysts’ expectations of $823.55 million. During the same quarter last year, the company posted $0.19 earnings per share. Surgery Partners’s revenue for the quarter was up 6.6% on a year-over-year basis. Surgery Partners has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Surgery Partners will post 0.67 earnings per share for the current year.

Insider Activity

In related news, insider Harrison R. Bane sold 9,339 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $22.48, for a total transaction of $209,940.72. Following the transaction, the insider directly owned 117,181 shares of the company’s stock, valued at approximately $2,634,228.88. The trade was a 7.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Surgery Partners

Several institutional investors and hedge funds have recently modified their holdings of the business. Creative Planning boosted its holdings in shares of Surgery Partners by 24.1% during the 3rd quarter. Creative Planning now owns 19,215 shares of the company’s stock worth $416,000 after buying an additional 3,728 shares during the period. Raymond James Financial Inc. lifted its holdings in shares of Surgery Partners by 34.8% during the 3rd quarter. Raymond James Financial Inc. now owns 833,637 shares of the company’s stock worth $18,040,000 after acquiring an additional 215,377 shares during the period. Freestone Grove Partners LP acquired a new stake in Surgery Partners during the third quarter valued at approximately $7,743,000. California State Teachers Retirement System boosted its stake in Surgery Partners by 12.4% in the 3rd quarter. California State Teachers Retirement System now owns 73,140 shares of the company’s stock valued at $1,583,000 after buying an additional 8,049 shares in the last quarter. Finally, Two Sigma Investments LP increased its position in shares of Surgery Partners by 23.1% during the 3rd quarter. Two Sigma Investments LP now owns 22,034 shares of the company’s stock worth $477,000 after purchasing an additional 4,137 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.